Tatjana Kolevska

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Albert Lai, Anh Tran, Phioanh L. Nghiemphu et al. · Journal of Clinical Oncology · 2010 · 451 citations · Full text

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Michele Maio, Karl D. Lewis, Lev Demidov et al. · The Lancet Oncology · 2018 · 210 citations · Full text

Medicine, Melanoma, Immunology +10

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma

John P. Leonard, Kathryn S. Kolibaba, James A. Reeves et al. · Journal of Clinical Oncology · 2017 · 187 citations

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

Alberto Chiappori, Tatjana Kolevska, David R. Spigel et al. · Annals of Oncology · 2014 · 177 citations · Full text

Telomerase Inhibitor Imetelstat, Medicine, Pharmacology +7

A Randomized Controlled Trial of mHealth Mindfulness Intervention for Cancer Patients and Informal Cancer Caregivers: A Feasibility Study Within an Integrated Health Care Delivery System

Ai Kubo, Elaine Kurtovich, MegAnn K McGinnis et al. · Integrative Cancer Therapies · 2019 · 168 citations · Full text